2023年10月9日 · Cardiovascular-kidney-metabolic (CKM) syndrome is defined as a health disorder attributable to connections among obesity, diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD), including heart failure, atrial fibrillation, coronary heart disease, stroke, and peripheral artery disease.

2024年1月15日 · 2023年10月，美国心脏协会（AHA）发表了关于心血管-肾脏-代谢综合征（CKM）的主席建议，将CKM定义为一种健康紊乱，是由肥胖、糖尿病、慢性肾脏疾病和心血管疾病之间病理生理相互作用导致的全身性疾病。 CKM综合征既包括存在代谢危险因素和/或慢性肾脏病（CKD）而具有心血管疾病（CVD）风险的患者，也包括合并代谢危险因素或CKD的已经存在CVD的患者。 政策、经济和环境因素对生活方式和自我保健的不利影响进一步强化了CKM综 …

Cardiovascular-kidney-metabolic (CKM) syndrome is a health disorder due to connections among heart disease, kidney disease, diabetes, and obesity leading to poor health outcomes.

1.心血管-肾脏-代谢综合征（CKM，Cardiovascular-Kidney-Metabolic syndrome）： CKM综合征是一种系统性疾病，其特征在于 代谢风险因素 、 慢性肾病 （CKD）和心血管系统 之间的病理生理相互作用，导致多器官功能障碍和较高的心血管不良事件发生率。 CKM综合征包括因存在代谢风险因素、CKD或两者兼有而处于心血管疾病（CVD）风险中的个体，以及因代谢风险因素或CKD而潜在相关或复杂化的已有CVD的个体。 政策、经济和环境导致的生活方式和自我护理 …

2024年10月9日 · Sodium-glucose co-transporter 2 (SGLT2) inhibitors, originally developed for glucose-lowering effects, represent a cornerstone therapy in the management of cardiovascular-kidney-metabolic (CKM) syndrome .

2024年11月1日 · The recent conceptualization of the cardiovascular-kidney-metabolic (CKM) syndrome by the American Heart Association (AHA) opens an opportunity for a multidisciplinary and lifelong approach in the risk stratification, early prevention, and treatment of the vicious circle generated by the interaction of cardiovascular, renal and metabolic risk ...

2024年11月22日 · Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as game-changers across the cardiovascular–kidney–metabolic (CKM) spectrum: overweight/obesity, type 2 diabetes mellitus (T2DM) and associated chronic kidney disease (CKD) and cardiovascular disease (CVD).

CKM syndrome (cardiovascular-kidney-metabolic syndrome) is a newly named medical condition that affects most of your major organs, like your heart, kidneys, brain and liver. This complex disorder consists of four related medical issues and notes the links between them. These conditions are: Cleveland Clinic is a non-profit academic medical center.

2023年10月9日 · Poor cardiovascular-kidney-metabolic (CKM) health is a major determinant of premature morbidity and mortality. Consequently, developing comprehensive strategies to augment CKM health across the life course is a key clinical and public health priority.

2024年6月26日 · 2023年10月美国心脏协会AHA主席建议提出“心-肾-代谢综合征(Cardiovascular-kidney-metabolic syndrome，CKM)”新概念，引发全球对于心肾共治及代谢性疾病防治的广泛关注 1 ，CKM也被AHA评为“2023年度心血管疾病防治领域9项重大进展”。